The Efficiency Of The Methotrexate At Patients Affected By Grave Pelade
Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
Alopecia areata (AA) is an auto immune disorder. Treatment of severe types remains difficult
with a rate of hair regrowth which is lower than 10%. This RCT will assess the safety and
efficacy of methotrexate alone or associated with low doses of prednisone versus placebo in
the treatment of severe types of AA.